[1]
Erdem, G.U., Bozkaya, Y., Ozdemir, N.Y., Demirci, N.S., Yazici, O. and Zengin, N. 2018. 5-fluorouracil, leucovorin, and irinotecan (FOLFIRI) as a third-line chemotherapy treatment in metastatic gastric cancer, after failure of fluoropyrimidine, platinum, anthracycline, and taxane. Bosnian Journal of Basic Medical Sciences. 18, 2 (May 2018), 170-177. DOI:https://doi.org/10.17305/bjbms.2017.2258.